Korea's GCCL leverages ddPCR to enhance cell, gene therapy clinical trial services
Singapore, May 22 -- To differentiate global lab services for cell and gene therapy clinical trials with cutting-edge technology.
Global Clinical Central Lab (GCCL), a Korean clinical trial sample analysis company, has introduced Droplet Digital PCR devices (ddPCR) for the first time in the domestic clinical trial sample analysis industry, enhancing its capabilities in analysing samples for cell and gene therapy clinical trials.
Currently, real-time PCR analysis is widespread in the field of clinical trial sample analysis for cell and gene therapy. However, the existing analysis methods have limitations such as relying on calibration reference standard samples for relative quantification, low analysis efficiency due to manual labor, and...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.